Effective response to crizotinib of concurrent KIF5B-MET and MET-CDR2-rearranged non-small cell lung cancer: A case report

doi:10.12998/wjcc.v10.i8.2529

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 8

This Article

Academic Content and Language Evaluation of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4109)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-1) series.

Item

Count

PDF

265

WORD

234

HTML

2132

Figures (1-3)

318

Tables (1-1)

326

Sum=3275

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

263

Download

571

Sum=834

Mar 16, 2022 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Clin Cases. Mar 16, 2022; 10(8): 2529-2536
Published online Mar 16, 2022. doi: 10.12998/wjcc.v10.i8.2529

Full Size Figure Download Figure

Figure 3 Clinical efficacy of crizotinib treatment in a patient with KIF5B-MET and MET-CDR2-rearranged, poorly differentiated lung cancer. A: Thoracic computed tomographic image at baseline; B: 1 mo after initiating crizotinib therapy; C and D: After disease progression and another 2 mo later in May, 2019.

Citation: Liu LF, Deng JY, Lizaso A, Lin J, Sun S. Effective response to crizotinib of concurrent KIF5B-MET and MET-CDR2-rearranged non-small cell lung cancer: A case report. World J Clin Cases 2022; 10(8): 2529-2536
URL: https://www.wjgnet.com/2307-8960/full/v10/i8/2529.htm
DOI: https://dx.doi.org/10.12998/wjcc.v10.i8.2529